Guided by leading voices in psychedelic medicine

Tom is an experienced psychotherapist, clinical supervisor, mentor and consultant committed to the ethical development of psychedelic medicines. Drawing on over 15 years of experience in psychedelic work, his practice spans retreat facilitation, harm reduction, and post-experience integration.

He currently works as a research therapist on clinical trials involving Ibogaine, 5-MeO-DMT, Psilocybin, DMT and Methylone, alongside his private practice at Tom Shutte Therapy, supporting individuals through therapeutic and integrative work.

Tom is a contributing author to the Manual of Psychedelic Support and previously held the role of Clinical Lead at Wavepaths, a company pioneering personalised music for psychedelic therapy. His work bridges clinical research, therapeutic practice, and the evolving standards of care within psychedelic-assisted therapy.

Raggi is a BACP and NCPS-registered psychotherapist with over 4,000 clinical hours and seven years of formal training, specialising in trauma, addiction, burnout and identity transformation. Her work supports high-performing professionals to explore the deeper patterns beneath surface success, helping those who feel disconnected or dysregulated move toward more embodied, conscious and aligned ways of living and working.

She has particular expertise in identity reconstruction and the integration of psychedelic and non-ordinary state experiences, bridging therapeutic practice with emerging models of care.

Raggi brings a rare dual perspective, combining two decades of leadership in recruitment with advanced training in psychedelic studies and mind-body therapies. She holds an MSc in Addiction Psychology and a PGCert in Psychedelics: Mind, Body and Culture from the University of Exeter.

Alongside her clinical practice at Essential Minds, she contributes to psychedelic therapy frameworks informed by MAPS and Johns Hopkins University models, speaks publicly on addiction and workplace stress, and is currently writing a book on psychedelic-informed therapy.

Tali Avron is a Clinical Trial Manager specialising in psychedelic research and medical cannabis, with a strong background in pharmaceuticals and healthcare. She has extensive experience managing clinical and observational studies from inception through to completion, ensuring compliance with GCP standards and navigating the regulatory complexities of emerging therapies.

Her work sits at the intersection of academia, industry and harm reduction, where she focuses on advancing evidence-based approaches to psychedelic-assisted therapy. Tali has led protocol development, regulatory submissions, cross-functional collaboration and training, supporting the delivery of safe and effective clinical research across diverse settings.

She has a particular interest in bridging traditional, underground and clinical perspectives, working to integrate these approaches through research, education and policy development. Her focus is on developing scalable models of care that prioritise participant safety, accessibility and ethical best practice.

Alongside her research work, Tali is Co-Founder of the Psychedelic Women Network, a global initiative supporting inclusion and collaboration across the field, and contributes to public dialogue through speaking, education, mentorship and advocacy.

Dr Paul Collins is a psychiatrist and anthropologist with over 11 years of senior NHS and private-sector clinical experience, spanning acute care, crisis intervention, community services, and extensive work in forensic and prison settings. His practice integrates psychiatry, social anthropology and systems thinking to explore the full spectrum of human experience.

He originally trained in Social Anthropology at SOAS before founding and running a rehabilitation social enterprise for 10 years. He later retrained in medicine at St George's University of London and completed MRCPsych in 2017.

His current work focuses on human-AI symbiosis in mental health, and he has developed several open-source frameworks including Flourish OS, First Breath and Spiral State Psychiatry.

Alongside his clinical and research work, Paul runs a private practice at Flourish Psychiatry, bringing a unique perspective on holistic psychiatry, psychedelic-informed care and the future of collaborative AI in clinical practice.

Himesh Mehta is a doctoral researcher in the History Department at the University of Warwick, specialising in the history of psychedelic-assisted therapies, consciousness studies and global healing traditions. His research examines how cultural, political and scientific forces shape the development, regulation and practice of psychedelic medicine.

He holds a First-Class BA in History from King's College London and an MA in Global History from Warwick. His work explores the intersection of ritual, ethics, therapy and policy, drawing on cross-cultural perspectives and contemporary clinical research.

Himesh contributes to MindPsy by providing deep contextual insight into the emerging psychedelic ecosystem, helping ensure that talent evaluation, sector partnerships and community-building are grounded in historical understanding, integrity and cultural awareness.